Compass Pathways' depression drug succeeds late-stage trial-March 2024-www.financetom.com

Compass Pathways' depression drug succeeds late-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025 4:09 AM

June 23 (Reuters) - Compass Pathways ( CMPS ) said on

Monday its experimental psilocybin-based therapy helped

significantly reduce symptoms of difficult-to-treat depression

in a late-stage study.

(Reporting by Mariam Sunny and Christy Santhosh in Bengaluru;

Editing by Mrigank Dhaniwala)

Previous page： CommScope Faces Limited AI Upside, Debt Challenges Into 2025, Morgan Stanley Says Next page： US watchdog finalizes new rule on solar panel, home equity loans

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CommScope Faces Limited AI Upside, Debt Challenges Into 2025, Morgan Stanley Says

Dec 17, 2024

11:35 AM EST, 12/17/2024 (MT Newswires) -- CommScope Holding ( COMM ) faces a less attractive risk-reward setup heading into 2025, Morgan Stanley said in a note Wednesday, citing limited upside from AI and challenges in addressing upcoming debt maturities. The firm noted that while CommScope's ( COMM ) earnings before interest, taxes, depreciation and amortization are expected to grow...

US watchdog finalizes new rule on solar panel, home equity loans

Dec 17, 2024

(Reuters) - The U.S. watchdog agency for consumer finance on Tuesday finalized new regulations it said would protect home improvement borrowers who finance solar panels and other purchases through their property taxes, the agency said. The announcement from the U.S. Consumer Financial Protection Bureau came amid continued Republican demands from Capitol Hill that President Joe Biden's administration cease adopting new...

Blackberry Target Lifted to US$3.25 at RBC on Cylance Sale

Dec 17, 2024

11:34 AM EST, 12/17/2024 (MT Newswires) -- RBC has raised its one year target on Blackberry to US$3.25, from US$3, to reflect BlackBerry's sale of Cylance, which comes at a higher than expected takeout price. The sale eliminates a major overhang on BlackBerry's shares, notes analyst Paul Treiber. However, even without Cylance, BlackBerry is still seeing relatively slow growth, given...

Tesla castigates German union over attempt to oust works council head

Dec 17, 2024

FRANKFURT, Dec 17 (Reuters) - Tesla accused Germany's IG Metall union of trying to sow unrest at the EV maker's gigafactory near Berlin by seeking to oust the head of the works council, in the latest sign of the sour relationship between the two sides. IG Metall, Germany's most powerful union, said earlier it had filed a motion with a...